Skip to Content

Study shows Remdesivir significantly reduces Covid hospitalizations

(KYMA, KECY/ CNN) - A new study found that the antiviral drug Remdesivir significantly reduces the risk of hospitalization among high-risk Covid-19 patients.

The drug was tested on 562 people considered high-risk for severe Covid-19 based on their health conditions and age. Half of them received the drug and other half received a placebo.

The group that got the drug saw an 87% reduction in risk of hospitalization by day 28 an there was an 81% reduced risk of dying compared with the group that got a placebo.

The antiviral was the first drug to be approved by the U.S. Food and Drug Administration to treat Covid-19. It is approved for treatment of hospitalized adult and pediatric patients age 12 and older, and has emergency use authorization for treatment of younger children.

It is approved for use only in a hospital or health care setting and needs to be administered by an IV.

CNN

Author Profile Photo

Cole Johnson

Cole grew up in a small town of just over 3,000 people called Moravia, NY—home of President Millard Fillmore and Fillmore Glen State Park.

He is eager to wake up every morning with the Desert Southwest and give viewers the greatest coverage to start their day.

Contact Cole at cole.johnson@kecytv.com.

Skip to content